With Second Licensing Deal In A Month, Ikaria Adds To Critical Care Pipeline
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with Fibrex Medical brings Ikaria a Phase II cardiology drug plus two preclinical compounds.